Increased airway hyperreactivity in response to methacholine in patients with asthma positively correlates with IL-17A levels in the sputum [13] and a polymorphism in IL-17F that results in a loss-of-function mutation is inversely related to asthma risk [14]. Here, IL17F is linked to asthma.